Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back


Abd Elgadir A Altoum

Gulf Medical University, Ajman, UAE

Biography

Objective: The objective of the current study is to compare the levels of oxidative stress markers malondialdehyde (MDA), zinc, and antioxidant Vitamins (A, E, and C) in ischemic heart disease (IHD) and non-IHD patients with diabetes mellitus.
Method: This is cross-sectional study group, conducted in the advanced diagnostic center (Khartoum- Sudan). Comprised 100 healthy subjects were, control group with mean (fasting blood sugar) 5.61=m mol/L, the age ranged from 22 to 78 years old, the average of the age was 50.1 years. 300 patients (78 IHD and 222 without) as cases groups, the ages ranged from 30 to 80 years. The age average was 51.2 years, all samples were in a state of fasting for 12 h, and the data were collected using a structured questionnaire and direct interview to collect information. Blood specimens were collected from both groups, and plasma levels of MDA, zinc, and antioxidant Vitamins (A, E, and C) were determined.
Results: There was a significant difference between the level of serum Vitamin A, E, Zinc and MDA in diabetic patients with IHD and those diabetic
without IHD (p<0.05). No significant differences in serum Vitamin C level between both groups (p>0.05).
Conclusion: Due to the significant differences in serum Vitamin A, E, Zinc, and MDA between diabetics with IHD and diabetics without IHD, these
parameters can be used as prognostic markers for prediction of oxidative stress and antioxidant stress of diabetic patients with IHD complications
 

Abstract

Abstract : Study Of Levels Of Selective Oxidative Stress Markers (Malondialdehyde, Zinc, And Antioxidant Vitamins A, E, And C) In Ischemic And Non-Ischemic Heart Disease Patients Suffering From Type- 2 Diabetes